Presented by: Dr. Hestia Mellert
Senior Director, Development
Biodesix
Home
WEBINAR: Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC
Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC
Presented by: Dr. Hestia Mellert
Senior Director, Development
Biodesix
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
CORPORATE HEADQUARTERS
919 W. Dillon Rd. | Louisville,
CO 80027
Phone (303) 417-0500
Fax (866) 432-3338
© Copyright 2024 Biodesix.
All Rights Reserved.